Non-competitive Inhibitors
**Core Concept**
Non-competitive inhibitors are a type of enzyme inhibitor that binds to an enzyme at a location other than the active site, altering the enzyme's shape and reducing its ability to bind to its substrate. This type of inhibition is characterized by a decrease in the maximum velocity (Vmax) of the enzyme reaction without affecting the enzyme's affinity for the substrate (Km).
**Why the Correct Answer is Right**
Non-competitive inhibitors bind to a region of the enzyme called the allosteric site, which is distinct from the active site where the substrate binds. This binding causes a conformational change in the enzyme, reducing its ability to bind to the substrate and thereby decreasing the Vmax of the reaction. The inhibition is non-competitive because the inhibitor does not compete with the substrate for binding to the active site.
**Why Each Wrong Option is Incorrect**
**Option A:** This option may refer to competitive inhibitors, which bind to the active site of the enzyme and compete with the substrate for binding. While they do decrease the Vmax, they also increase the Km, which is not characteristic of non-competitive inhibition.
**Option B:** This option may refer to irreversible inhibitors, which bind covalently to the enzyme and permanently inactivate it. This type of inhibition can be either competitive or non-competitive, but it is not a characteristic of non-competitive inhibition.
**Option C:** This option may refer to uncompetitive inhibitors, which bind to the enzyme-substrate complex and decrease both the Vmax and Km. While they do decrease the Vmax, they also decrease the Km, which is not characteristic of non-competitive inhibition.
**Clinical Pearl / High-Yield Fact**
Non-competitive inhibitors can be reversible or irreversible, and their effects can be overcome by increasing the substrate concentration or adding a substrate that can outcompete the inhibitor for binding.
**Correct Answer: D. Non-competitive inhibitors bind to an enzyme at a location other than the active site, altering the enzyme's shape and reducing its ability to bind to its substrate.**